ArticlePharmacoEconomics2003
A role for two-stage pharmacoeconomic appraisal? Is there a role for interim approval of a drug for reimbursement based on modelling studies with subsequent full approval using phase III data?
Suzanne Hill et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it